Scientists in Switzerland have developed a simple and cheap way to synthesise amines - compounds that form the backbone of many active pharmaceutical ingredients.
SGS will soon be able to test up to 30 batches of amino acids for impurities per month after adding new analytical methods to those offered at its laboratory in Taunusstein, Germany.
Chiral Quest parent VioQuest Pharmaceuticals has been awarded a US
patent covering the use of novel catalysts to increase the
efficiency of chiral amine and amino acid synthesis.
Germany's BASF has entered into a collaboration with Solvias of
Switzerland that will see the two companies combine their expertise
in the development and manufacture of chiral intermediates for the
life science industry.
Eastman Chemical has extended its agreement with Johnson Matthey
subsidiary Alfa Aesar in a move that will for the first time make
its proprietary BoPhoz catalyst ligands available in research
quantities.
German chemistry specialist ChiroBlock has pulled out of the
business of producing and marketing chiral compounds and will focus
exclusively on providing chiral research and synthesis services for
pharmaceutical and biotechnology...
A lactose product developed by DMV International of the
Netherlands, Pharmatose DCL14, has properties that give it
performance advantages over rival excipients used as
filler/binders, according to the company.
Germany's Chiracon, a specialist in novel raw and starting
materials for high-value pharmaceuticals, has joined the circle of
Startup-Partners, the central capital marketing agency for Berlin.
Life science company Chiral Quest this week announced that the
non-profit organisation, the Penn State Research Foundation, has
received a US patent covering the compositions of matter and use
for a series of chiral phosphine ligands...
